raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:263440

Neuroacanthocytosis

Type
Clinical group
Group
Group of disorders
Status
active

Neuroacanthocytosis (NA) syndromes are a group of genetic diseases characterized by the association of red blood cell acanthocytosis (deformed erythrocytes with spike-like protrusions) and progressive degeneration of the basal ganglia.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enNeuroacanthocytosis
frNeuroacanthocytose
deNeuroakanthozytose
esNeuroacantocitosis
itNeuroacantocitosi
nlNeuroacanthocytose
ptNeuroacantocitose
plNeuroakantocytoza
csNeuroakantocytóza
ukНейроакантоцитоз
zh神经棘红细胞增多症
trNöroakantositoz

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
MONDO0016987Evalidated
MONDO16987Evalidated
MeSHD054546Evalidated
UMLSC0393576Evalidated
GARD10902Evalidated
MedDRA10081506Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (5):

Children (4):

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Point prevalence<1 / 1 000 000—WorldwideClass onlyNot yet validated22027213[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card